| Accession Number | 0001992260-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 2, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Head of R&D | Common Stock | โ | Jun 1, 2026 | Exercise/Conversion | 3,998 | $8.44 | $33,743.12 | 7,998 | Direct | โ | View Details | |
EVP, Head of R&D | Common Stock | โ | Jun 1, 2026 | Exercise/Conversion | 6,908 | $17.88 | $123,515.04 | 14,906 | Direct | โ | View Details | |
EVP, Head of R&D | Common Stock | โ | Jun 1, 2026 | Exercise/Conversion | 6,249 | $21.77 | $136,040.73 | 21,155 | Direct | โ | View Details | |
EVP, Head of R&D | Common Stock | โ | Jun 1, 2026 | Exercise/Conversion | 9,375 | $22.07 | $206,906.25 | 30,530 | Direct | โ | View Details | |
EVP, Head of R&D | Common Stock | โ | Jun 1, 2026 | Sale | 5,428 | $89.72 | $487,000.16 | 25,102 | Direct | โ | View Details | |
EVP, Head of R&D | Common Stock | โ | Jun 1, 2026 | Sale | 16,943 | $90.72 | $1,537,068.96 | 8,159 | Direct | โ | View Details | |
EVP, Head of R&D | Common Stock | โ | Jun 1, 2026 | Sale | 4,159 | $91.37 | $380,007.83 | 4,000 | Direct | โ | View Details | |
EVP, Head of R&D | Stock Option (Right to Buy) | Derivative | Jun 1, 2026 | Exercise/Conversion | 3,998 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
EVP, Head of R&D | Stock Option (Right to Buy) | Derivative | Jun 1, 2026 | Exercise/Conversion | 6,908 | $0.00 | $0.00 | 64,276 | Direct | โ | View Details | |
EVP, Head of R&D | Stock Option (Right to Buy) | Derivative | Jun 1, 2026 | Exercise/Conversion | 6,249 | $0.00 | $0.00 | 47,925 | Direct | โ | View Details | |
EVP, Head of R&D | Stock Option (Right to Buy) | Derivative | Jun 1, 2026 | Exercise/Conversion | 9,375 | $0.00 | $0.00 | 96,875 | Direct | โ | View Details |